Hualan Biological Bacterin Inc.
301207.SHE
| Exchange: | SHE |
| Currency | Renminbi |
| Fiscal Year End: | December |
| Sector: | Healthcare |
| Industry: | Biotechnology |
| Gic Sector: | Health Care |
| Gic Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| Gic Industry: | Biotechnology |
| Gic Sub Industry: | Biotechnology |
| Description: | Hualan Biological Vaccine Inc. engages in the research, development, production, and sale of vaccines in China. It offers influenza virus split vaccines, quadrivalent influenza virus split vaccines, H1N1 influenza virus split vaccines, ACYW135 meningococcal polysaccharide plague vaccines, recombinant hepatitis B vaccines, and group A and C meningococcal polysaccharide vaccines, as well as genetic engineering vaccines for human use. The company was founded in 2005 and is based in Xinxiang, China. |
| Address: | No. 1-A-1, Hualan Avenue, Xinxiang, China, 453003 |
| Website: | https://www.hualanbacterin.com |
| Full Time Employees: | 770 |
| Updated On: | 2024-11-02 |
Highlights
| Market Capitalization: | 11221192704 |
| Market Capitalization Mln: | 11221.19 |
| EBITDA: | 589679360 |
| PE Ratio: | 14.47 |
| Wall Street Target Price: | 33.2 |
| Book Value: | 10.24 |
| Dividend Share: | 0.6 |
| Dividend Yield: | 0.03 |
| Earnings Share: | 1.29 |
| Most Recent Quarter: | 2024-06-30 |
| Profit Margin: | 0.30 |
| Operating Margin TTM: | 0.27 |
| Return On Assets TTM: | 0.03 |
| Return On Equity TTM: | 0.08 |
| Revenue TTM: | 1649523584 |
| Revenue Per Share TTM: | 2.74 |
| Quarterly Revenue Growth YOY: | -0.41 |
| Gross Profit TTM: | 1456451341 |
| Diluted Eps TTM: | 1.29 |
| Quarterly Earnings Growth YOY: | -0.53 |
Valuation
| Trailing PE: | 14.47 |
| Price Sales TTM: | 7.07 |
| Price Book MRQ: | 1.89 |
| Enterprise Value: | 8992742145 |
| Enterprise Value Revenue: | 3.91 |
| Enterprise Value Ebitda: | 8.52 |
Shares
| Shares Outstanding: | 601027968 |
| Shares Float: | 76636004 |
| Percent Insiders: | 85.89 |
| Percent Institutions: | 2.94 |
Technicals
| Beta: | 0.80 |
| 52 Week High: | 31.52 |
| 52 Week Low: | 15.42 |
| 50 Day MA: | 17.99 |
| 200 Day MA: | 20.50 |
Splits & Dividends
| Forward Annual Dividend Rate: | 0.6 |
| Forward Annual Dividend Yield: | 0.03 |
| Payout Ratio: | 1.40 |
| Ex Dividend Date: | 2024-06-14 |
| Last Split Factor: | 1.5:1 |
| Last Split Date: | 2023-06-07 |
Earnings
| Report Date: | 2024-10-29 |
| Date: | 2024-09-30 |
| Before After Market: | After Market |
| Currency: | CNY |
| Report Date: | 2024-06-30 |
| Date: | 2024-06-30 |
| Currency: | CNY |
| Eps Actual: | -0.02 |
| Report Date: | 2024-04-25 |
| Date: | 2024-03-31 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.06 |
| Report Date: | 2024-03-29 |
| Date: | 2023-12-31 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.38 |
| Report Date: | 2023-10-27 |
| Date: | 2023-09-30 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.86 |
| Report Date: | 2023-08-23 |
| Date: | 2023-06-30 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.02 |
| Report Date: | 2023-04-21 |
| Date: | 2023-03-31 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.23 |
| Report Date: | 2023-03-29 |
| Date: | 2022-12-31 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.04 |
| Report Date: | 2022-10-30 |
| Date: | 2022-09-30 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.52 |
| Report Date: | 2022-08-22 |
| Date: | 2022-06-30 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | 0.8 |
| Report Date: | 2022-04-29 |
| Date: | 2022-03-31 |
| Before After Market: | After Market |
| Currency: | CNY |
| Eps Actual: | -0.00 |
| Date: | 2024-09-30 |
| Eps Actual: | 0.04 |
| Date: | 2023-12-31 |
| Eps Actual: | 1.51 |
| Date: | 2022-12-31 |
| Eps Actual: | 1.35 |